| 55 | CETUXIMAB PLUS FOLFOX-4 IN UNTREATED PATIENTS WITH ADVANCED COLORECTAL CANCER: A GRUPPO ONCOLOGICO DELL’ITALIA MERIDIONALE MULTICENTER PHASE II STUDY | G. Colucci, F. Giuliani, C. Garufi, R. Mattioli, L. Manzione, A. Russo, M. Lopez, P. Parrella, S. Tommasi, M. Copetti, B. Daniele, S. Pisconti, G. Tuveri, N. Silvestris, E. Maiello | Oncology, 2010; 79:415-22 | 2.538
| 2.422 |
| 56 | RANDOMIZED PHASE III TRIAL OF GEMCITABINE PLUS CISPLATIN COMPARED WITH SINGLE-AGENT GEMCITABINE AS FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED PANCREATIC CANCER: THE GIP-1 STUDY | G. Colucci, R. Labianca, F. Di Costanzo, V. Gebbia, G. Cartenì, B. Massidda, E. Dapretto, L. Manzione, E. Piazza, M. Sannicol, M. Ciaparrone, L. Cavanna, F. Giuliani, E. Maiello, A. Testa, P. Pederzoli, M. Falconi, C. Gallo, M. Di Maio, F. Perrone | Journal of Clinical Oncology, 2010; 28:1645-1651 | 18.97 | 18.428 |
